When Side Effects Push Users Away Additionally, people who had previously used gastrointestinal medicationswhich may indicate they are more vulnerable to the common adverse gastrointestinal side-effects reported by GLP1-RA users, such as nausea, vomiting, diarrheawere 9% more likely to discontinue semaglutide within the first year
As research continues to evolve, healthcare providers are encouraged to stay informed about the latest findings related to tirzepatide, semaglutide, and other weight management therapies
Compounding exists when FDA approved drugs are in shortage or a prescriber for an individual patient needs a custom formulation of a drugneeds it in a dosage form, or a dosage strength, or a combination that is not commercially available, not FDA approved. Brunner said that APC is at heart an advocacy organization. Compounding is an essential therapy in the American health care system
Drugs like these have completely revolutionized how doctors treat diabetes and weight loss, and frankly, it seems like there's another new use for them announced every few weeks